Symbols / RLAY Stock $16.98 +3.54% Relay Therapeutics, Inc.
RLAY (Stock) Chart
About
No company description available for this symbol.
Stock Fundamentals
Scroll to Statements| Market Cap | 2.67B | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $16.40 | Price | $16.98 | Change | 3.54% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
- Relay Therapeutics (RLAY) Stock: Is It a Good Buy | Q4 2025: EPS Beats Forecasts - Real-time Trade Ideas - UBND thành phố Hải Phòng hu, 23 Apr 2026 03
- Relay Therapeutics (RLAY) surges 16.4%: Is this an indication of further gains? - MSN Wed, 22 Apr 2026 16
- Is Relay Therapeutics (RLAY) stock strengthening its trend | Q4 2025: EPS Beats Forecasts - Community Buy Alerts - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 01
- Catinazzo, Relay Therapeutics CFO, sells $257k in RLAY stock - Investing.com hu, 09 Apr 2026 07
- RLAY SEC Filings - Relay Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan Sun, 19 Apr 2026 22
- RLAY PE Ratio & Valuation, Is RLAY Overvalued - Intellectia AI hu, 23 Apr 2026 05
- Relay Therapeutics (RLAY) Stock: Stability Assessment (Buying Pressure) 2026-04-18 - Intraday Trading - Cổng thông tin điện tử Tỉnh Sơn La Sat, 18 Apr 2026 23
- Relay Therapeutics (RLAY) Stock: Is It a Good Buy | Q4 2025: EPS Beats Forecasts - Market Perform - Xã Thanh Hà hu, 23 Apr 2026 05
- Here's Why Relay Therapeutics, Inc. (RLAY) is a Great Momentum Stock to Buy - Yahoo Finance ue, 28 Oct 2025 07
- $RLAY stock is up 19% today. Here's what we see in our data. - Quiver Quantitative Mon, 24 Nov 2025 08
- First zovegalisib results in about 20 vascular anomaly patients due in May - Stock Titan hu, 02 Apr 2026 07
- Is Relay Therapeutics (RLAY) stock gaining momentum (Mini Selloff) 2026-04-20 - Fast Moving Stocks - Xã Vĩnh Công Mon, 20 Apr 2026 16
- Relay Therapeutics (RLAY) climbs 16% ahead of cancer treatment update - MSN Fri, 03 Apr 2026 09
- Healthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earnings - Seeking Alpha ue, 07 Apr 2026 07
- Relay Therapeutics (RLAY) Is Up 30.6% After Expanding Zovegalisib Into Vascular Anomalies Data Reveal - Yahoo Finance Sat, 04 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
15.36
+53.44%
|
10.01
-60.83%
|
25.55
+1749.82%
|
1.38
|
| Operating Revenue |
|
15.36
+53.44%
|
10.01
-60.83%
|
25.55
+1749.82%
|
1.38
|
| Operating Expense |
|
318.09
-19.61%
|
395.68
-2.29%
|
404.97
+29.66%
|
312.33
|
| Research And Development |
|
261.38
-18.08%
|
319.09
-3.31%
|
330.02
+33.96%
|
246.35
|
| Selling General And Administration |
|
56.71
-25.96%
|
76.59
+2.19%
|
74.95
+13.60%
|
65.98
|
| General And Administrative Expense |
|
56.71
-25.96%
|
76.59
+2.19%
|
74.95
+13.60%
|
65.98
|
| Other Gand A |
|
56.71
-25.96%
|
76.59
+2.19%
|
74.95
+13.60%
|
65.98
|
| Total Expenses |
|
318.09
-19.61%
|
395.68
-2.29%
|
404.97
+29.66%
|
312.33
|
| Operating Income |
|
-302.74
+21.50%
|
-385.67
-1.65%
|
-379.42
-22.02%
|
-310.95
|
| Total Operating Income As Reported |
|
-302.74
+18.72%
|
-372.47
+0.14%
|
-373.00
-24.63%
|
-299.27
|
| EBITDA |
|
-299.18
+21.31%
|
-380.21
-1.62%
|
-374.15
-21.94%
|
-306.82
|
| Normalized EBITDA |
|
-299.18
+23.95%
|
-393.42
-3.37%
|
-380.57
-19.49%
|
-318.50
|
| Reconciled Depreciation |
|
3.56
-34.90%
|
5.46
+3.70%
|
5.27
+27.58%
|
4.13
|
| EBIT |
|
-302.74
+21.50%
|
-385.67
-1.65%
|
-379.42
-22.02%
|
-310.95
|
| Total Unusual Items |
|
0.00
-100.00%
|
13.21
+105.64%
|
6.42
-45.00%
|
11.68
|
| Total Unusual Items Excluding Goodwill |
|
0.00
-100.00%
|
13.21
+105.64%
|
6.42
-45.00%
|
11.68
|
| Special Income Charges |
|
0.00
-100.00%
|
13.21
+105.64%
|
6.42
-45.00%
|
11.68
|
| Other Special Charges |
|
—
|
—
|
—
|
—
|
| Restructuring And Mergern Acquisition |
|
0.00
+100.00%
|
-13.21
-105.64%
|
-6.42
+45.00%
|
-11.68
|
| Net Income |
|
-276.48
+18.13%
|
-337.71
+1.25%
|
-341.97
-17.72%
|
-290.51
|
| Pretax Income |
|
-276.48
+18.13%
|
-337.71
+1.25%
|
-341.97
-17.72%
|
-290.51
|
| Net Non Operating Interest Income Expense |
|
27.04
-22.19%
|
34.75
+11.92%
|
31.05
+253.35%
|
8.79
|
| Net Interest Income |
|
27.04
-22.19%
|
34.75
+11.92%
|
31.05
+253.35%
|
8.79
|
| Interest Income Non Operating |
|
27.04
-22.19%
|
34.75
+11.92%
|
31.05
+253.35%
|
8.79
|
| Interest Income |
|
27.04
-22.19%
|
34.75
+11.92%
|
31.05
+253.35%
|
8.79
|
| Other Income Expense |
|
-0.78
-105.87%
|
13.22
+106.43%
|
6.40
-45.06%
|
11.66
|
| Other Non Operating Income Expenses |
|
-0.78
-5642.86%
|
0.01
+177.78%
|
-0.02
+10.00%
|
-0.02
|
| Gain On Sale Of Security |
|
—
|
—
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-276.48
+18.13%
|
-337.71
+1.25%
|
-341.97
-17.72%
|
-290.51
|
| Net Income From Continuing Operation Net Minority Interest |
|
-276.48
+18.13%
|
-337.71
+1.25%
|
-341.97
-17.72%
|
-290.51
|
| Net Income From Continuing And Discontinued Operation |
|
-276.48
+18.13%
|
-337.71
+1.25%
|
-341.97
-17.72%
|
-290.51
|
| Net Income Continuous Operations |
|
-276.48
+18.13%
|
-337.71
+1.25%
|
-341.97
-17.72%
|
-290.51
|
| Normalized Income |
|
-276.48
+21.21%
|
-350.91
-0.72%
|
-348.39
-15.29%
|
-302.19
|
| Net Income Common Stockholders |
|
-276.48
+18.13%
|
-337.71
+1.25%
|
-341.97
-17.72%
|
-290.51
|
| Diluted EPS |
|
—
|
-2.36
+15.41%
|
-2.79
-7.72%
|
-2.59
|
| Basic EPS |
|
—
|
-2.36
+15.41%
|
-2.79
-7.72%
|
-2.59
|
| Basic Average Shares |
|
—
|
142.87
+16.55%
|
122.58
+9.22%
|
112.23
|
| Diluted Average Shares |
|
—
|
142.87
+16.55%
|
122.58
+9.22%
|
112.23
|
| Diluted NI Availto Com Stockholders |
|
-276.48
+18.13%
|
-337.71
+1.25%
|
-341.97
-17.72%
|
-290.51
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
843.98
|
| Current Assets |
|
770.10
|
| Cash Cash Equivalents And Short Term Investments |
|
750.09
|
| Cash And Cash Equivalents |
|
143.74
|
| Other Short Term Investments |
|
606.35
|
| Receivables |
|
0.00
|
| Accounts Receivable |
|
0.00
|
| Other Receivables |
|
—
|
| Prepaid Assets |
|
16.70
|
| Other Current Assets |
|
3.31
|
| Total Non Current Assets |
|
73.88
|
| Net PPE |
|
68.87
|
| Gross PPE |
|
92.45
|
| Accumulated Depreciation |
|
-23.58
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
3.52
|
| Construction In Progress |
|
1.58
|
| Other Properties |
|
83.53
|
| Leases |
|
3.83
|
| Goodwill And Other Intangible Assets |
|
2.30
|
| Other Non Current Assets |
|
2.71
|
| Total Liabilities Net Minority Interest |
|
91.98
|
| Current Liabilities |
|
30.27
|
| Payables And Accrued Expenses |
|
23.40
|
| Payables |
|
9.21
|
| Accounts Payable |
|
9.21
|
| Current Accrued Expenses |
|
14.19
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.70
|
| Current Debt And Capital Lease Obligation |
|
4.96
|
| Current Capital Lease Obligation |
|
4.96
|
| Current Deferred Liabilities |
|
0.00
|
| Current Deferred Revenue |
|
0.00
|
| Other Current Liabilities |
|
1.20
|
| Total Non Current Liabilities Net Minority Interest |
|
61.71
|
| Long Term Debt And Capital Lease Obligation |
|
48.50
|
| Long Term Capital Lease Obligation |
|
48.50
|
| Other Non Current Liabilities |
|
13.21
|
| Stockholders Equity |
|
752.00
|
| Common Stock Equity |
|
752.00
|
| Capital Stock |
|
0.13
|
| Common Stock |
|
0.13
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
127.46
|
| Ordinary Shares Number |
|
127.46
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
2,152.65
|
| Retained Earnings |
|
-1,400.58
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.20
|
| Other Equity Adjustments |
|
-0.20
|
| Total Equity Gross Minority Interest |
|
752.00
|
| Total Capitalization |
|
752.00
|
| Working Capital |
|
739.83
|
| Invested Capital |
|
752.00
|
| Total Debt |
|
53.47
|
| Capital Lease Obligations |
|
53.47
|
| Net Tangible Assets |
|
749.70
|
| Tangible Book Value |
|
749.70
|
| Restricted Common Stock |
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-235.46
+5.48%
|
-249.11
+17.05%
|
-300.32
-30.86%
|
-229.49
|
| Cash Flow From Continuing Operating Activities |
|
-235.46
+5.48%
|
-249.11
+17.05%
|
-300.32
-30.86%
|
-229.49
|
| Net Income From Continuing Operations |
|
-276.48
+18.13%
|
-337.71
+1.25%
|
-341.97
-17.72%
|
-290.51
|
| Depreciation Amortization Depletion |
|
3.56
-34.90%
|
5.46
+3.70%
|
5.27
+27.58%
|
4.13
|
| Depreciation |
|
3.56
-34.90%
|
5.46
+3.70%
|
5.27
+27.58%
|
4.13
|
| Depreciation And Amortization |
|
3.56
-34.90%
|
5.46
+3.70%
|
5.27
+27.58%
|
4.13
|
| Other Non Cash Items |
|
—
|
-13.21
-105.64%
|
-6.42
+45.00%
|
-11.68
|
| Stock Based Compensation |
|
62.42
-33.69%
|
94.14
+9.42%
|
86.03
+53.25%
|
56.14
|
| Asset Impairment Charge |
|
2.30
|
0.00
|
0.00
|
—
|
| Operating Gains Losses |
|
1.00
+1093.07%
|
-0.10
|
—
|
—
|
| Gain Loss On Investment Securities |
|
—
|
-0.10
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
1.00
|
0.00
|
0.00
|
—
|
| Change In Working Capital |
|
-23.31
-259.41%
|
14.62
+145.04%
|
-32.46
-388.62%
|
11.25
|
| Change In Receivables |
|
0.00
|
0.00
-100.00%
|
5.22
+1970.61%
|
-0.28
|
| Changes In Account Receivables |
|
0.00
|
0.00
-100.00%
|
0.31
+215.46%
|
0.10
|
| Change In Prepaid Assets |
|
1.61
+130.10%
|
-5.36
-15.23%
|
-4.65
-117.20%
|
-2.14
|
| Change In Payables And Accrued Expense |
|
-11.44
-211.41%
|
10.27
+207.07%
|
-9.59
-184.95%
|
11.29
|
| Change In Accrued Expense |
|
—
|
—
|
-32.14
-260.27%
|
20.06
|
| Change In Payable |
|
—
|
—
|
-2.39
-220.36%
|
1.99
|
| Change In Account Payable |
|
—
|
—
|
-2.39
-220.36%
|
1.99
|
| Change In Other Working Capital |
|
-11.95
-233.95%
|
8.92
+491.25%
|
1.51
+118.01%
|
-8.38
|
| Change In Other Current Assets |
|
—
|
—
|
0.00
|
0.00
|
| Change In Other Current Liabilities |
|
-1.53
-294.27%
|
0.79
+103.15%
|
-24.95
-331.94%
|
10.76
|
| Investing Cash Flow |
|
192.80
+569.29%
|
-41.08
-115.95%
|
257.63
+236.50%
|
-188.75
|
| Cash Flow From Continuing Investing Activities |
|
192.80
+569.29%
|
-41.08
-115.95%
|
257.63
+236.50%
|
-188.75
|
| Net PPE Purchase And Sale |
|
-0.41
+79.68%
|
-2.02
+51.09%
|
-4.13
+54.47%
|
-9.06
|
| Purchase Of PPE |
|
-0.41
+79.68%
|
-2.02
+51.09%
|
-4.13
+54.47%
|
-9.06
|
| Sale Of PPE |
|
—
|
—
|
—
|
—
|
| Capital Expenditure |
|
-0.41
+79.68%
|
-2.02
+51.09%
|
-4.13
+54.47%
|
-9.06
|
| Net Investment Purchase And Sale |
|
193.21
+594.58%
|
-39.06
-114.92%
|
261.76
+245.68%
|
-179.68
|
| Purchase Of Investment |
|
-122.97
+81.10%
|
-650.63
-68.76%
|
-385.54
+27.99%
|
-535.42
|
| Sale Of Investment |
|
316.18
-48.30%
|
611.56
-5.52%
|
647.30
+81.96%
|
355.74
|
| Net Business Purchase And Sale |
|
—
|
—
|
0.00
|
0.00
|
| Purchase Of Business |
|
—
|
—
|
0.00
|
0.00
|
| Financing Cash Flow |
|
1.60
-99.41%
|
270.15
+677.35%
|
34.75
-88.01%
|
289.91
|
| Cash Flow From Continuing Financing Activities |
|
1.60
-99.41%
|
270.15
+677.35%
|
34.75
-88.01%
|
289.91
|
| Net Common Stock Issuance |
|
0.00
-100.00%
|
265.89
+778.08%
|
30.28
-89.37%
|
284.74
|
| Proceeds From Stock Option Exercised |
|
1.60
-62.36%
|
4.26
-4.72%
|
4.47
-13.43%
|
5.17
|
| Changes In Cash |
|
-41.05
-104.88%
|
-20.04
-152.71%
|
-7.93
+93.82%
|
-128.32
|
| Beginning Cash Position |
|
126.41
-13.68%
|
146.44
-5.14%
|
154.37
-45.39%
|
282.70
|
| End Cash Position |
|
85.35
-32.48%
|
126.41
-13.68%
|
146.44
-5.14%
|
154.37
|
| Free Cash Flow |
|
-235.87
+6.08%
|
-251.12
+17.51%
|
-304.44
-27.62%
|
-238.55
|
| Amortization Of Securities |
|
-4.95
+59.81%
|
-12.31
-14.42%
|
-10.76
-1010.58%
|
1.18
|
| Common Stock Issuance |
|
0.00
-100.00%
|
265.89
+778.08%
|
30.28
-89.37%
|
284.74
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
265.89
+778.08%
|
30.28
-89.37%
|
284.74
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-09 View
- 8-K2026-03-16 View
- 42026-03-11 View
- 8-K2026-03-11 View
- 10-K2026-02-26 View
- 8-K2026-02-26 View
- 8-K2026-02-03 View
- 42026-01-29 View
- 42026-01-29 View
- 42026-01-29 View
- 42026-01-15 View
- 42026-01-15 View
- 42026-01-15 View
- 42026-01-15 View
- 42026-01-07 View
- 42025-11-06 View
- 42025-11-06 View
- 10-Q2025-11-06 View
- 8-K2025-11-06 View
- 42025-11-04 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|